International Patent: TREATING RHEUMATOID ARTHRITIS AND OTHER CONDITIONS THROUGH EPIGENETIC MODULATION VIA DUAL TARGETING OF VOLTAGE-GATED SODIUM CHANNELS

GENEVA, July 9 -- NAVEGA THERAPEUTICS, INC. filed a patent application (US2025/061463) for “TREATING RHEUMATOID ARTHRITIS AND OTHER CONDITIONS THROUGH EPIGENETIC MODULATION VIA DUAL TARGETING OF VOLTAGE-GATED SODIUM CHANNELS”. With publication no. WO/2026/147880, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/46

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....